Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
GLAS
Strong SellSinkerGlass House Brands Inc. · Healthcare · United States · $931M · Avg Vol: $4M/d
18
StockRankGet insider-trade alerts
Q
31
V
25
M
45
P/E (TTM)
—
ROE
-28.6%
D/E
0.4x
Dividend %
—
COMPANY DESCRIPTION
Glass House Brands is a California-based cannabis company involved in the cultivation, processing, and retail sale of cannabis products. It utilizes a vertically integrated business model, which allows it to maintain cost leadership and quality control in the highly competitive California market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 84.9M | 160.8M | 200.9M | 182.0M | 28.9% | 177.0M | 197.4M | 252.2M | 17.7% |
| EPS | -0.83 | -1.37 | 0.01 | -0.35 | — | -0.80 | -0.23 | 0.23 | 188.4% |
| Shares | 68.2M | 70.9M | 76.9M | 81.7M | +19.8% | 88.0M | — | — | — |
| Debt | 73.9M | 75.1M | 69.2M | 74.6M | 0.3% | 72.3M | — | — | — |
| Equity | 168.9M | 89.8M | 116.2M | 73.9M | -24.1% | — | — | — | — |
| Op CF | -40.8M | 23.2M | 28.4M | 11.4M | -29.8% | -20.3M | — | — | — |
| Inv CF | -29.2M | -12.7M | -10.3M | -27.7M | — | — | — | — | — |
| Fin CF | 30.1M | 7.9M | -13.7M | 2.7M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-13.5%
SMA 50SMA 200
Close
$8.14
RSI (14)
31.9
52W High
$13.93
From 52W High
0.6%
SCORE BREAKDOWN
Quality
31
ROIC
-5.9%38.4
ROE
-28.6%26.1
GP/Assets
17.7%39.9
Op. Margin
-6.4%28.9
FCF/Assets
-8.4%31.3
Piotroski
316.1
Int. Cover
-2.9x30.0
D/E Ratio
0.44x31.9
Current Ratio
1.33x21.0
Value
25
P/E (TTM)
—N/A
EV/EBITDA
-39.5x25.0
P/FCF
—N/A
P/B
10.9x10.8
P/S
4.7x42.9
Div Yield
—N/A
Momentum
45
52W High %
58%33.0
RS 6M
-9%54.2
SMA 50/200
1.09x73.9
EPS Rev 4W
-15.1%6.3
EPS Rev 12W
—N/A
EPS Improve
+128%80.0
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$931M
P/E (Forward)
39.5x
Gross Margin
31.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of GLAS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| GLAS | Glass House Brands Inc.(you) | $931M | 18 | Strong Sell |
| AQST | Aquestive Therapeutics, Inc. | $630M | 14 | Strong Sell |
| HROW | Harrow, Inc. | $1.5B | 29 | Sell |
| BIOA | BioAge Labs, Inc. | $443M | 9 | Strong Sell |
| VREO.CN | Vireo Growth Inc. | $552M | 33 | Sell |
| AKBA | Akebia Therapeutics, Inc. | $243M | 17 | Strong Sell |
| DERM | Journey Medical Corporation | $211M | 24 | Sell |
| LFCR | Lifecore Biomedical, Inc. | $172M | 16 | Strong Sell |
| ORGO | Organogenesis Holdings Inc. | $224M | 29 | Sell |
| AMLX | Amylyx Pharmaceuticals, Inc. | $3.9B | 30 | Sell |
Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.3%